Case study: drug-induced electrolyte changes.
D000959:Antihypertensive Agents / Q000009:adverse effects*; D004338:Drug Combinations / Q000009:adverse effects; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000009:adverse effects*; D008750:Methyldopa / Q000009:adverse effects; D008875:Middle Aged; D013148:Spironolactone / Q000009:adverse effects*; D014883:Water-Electrolyte Imbalance / Q000139:chemically induced*
D000959:Antihypertensive Agents; D004338:Drug Combinations; C016210:buthiazide, spironolactone drug combination; D006852:Hydrochlorothiazide; D013148:Spironolactone; D008750:Methyldopa